Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases
Read MoreFor the past few years, the central narrative that investors and analysts have used to weave the market and economy’s movements into a single, cohesive thread is the coronavirus. While just about everybody wants to relegate the pandemic to history, its effects are still having an impact on daily life, and on the market. Variants […]
Read MoreEvery year, market watchers and talking heads look for a central narrative that can weave the market and economy’s movements into a single cohesive thread. That storyline often focuses on one of any number of factors – economic, political, or social – that history has proved can impact the market in a material way. Through […]
Read MoreThe surging Omicron variant has helped underline the need for booster shots, including perhaps even a fourth jab, as Israel is currently trialing. So why are the stocks of leading COVID-19 vaccine makers tanking? Shares of Moderna have fallen almost 35% in the past month. BioNTech, whose mRNA technology is behind the Pfizer vaccine, has […]
Read MoreGrindrod Shipping Holdings Ltd. (GRIN) Grindrod Shipping Holdings Ltd., an international shipping company, owns, charters-in, and operates a fleet of dry bulk carriers and tankers worldwide. It operates a fleet of 23 owned dry bulk carriers and 8 long-term chartered-in dry bulk carriers that transport a range of bulk and breakbulk commodities, including ores, coal, […]
Read More(Bloomberg) — Shares tied to reopening trades from casinos to airlines surged in Asia on Monday after Pfizer Inc. said that its Covid-19 pill could reduce hospitalizations and deaths in high-risk patients by 89%. A Bloomberg gauge of Macau casino shares jumped 7.2%, the biggest move in over two months, while an index of Asia-Pacific […]
Read MoreVials of the Moderna Covid-19 vaccine. Guillaume Souvant/AFP via Getty Images Moderna shares plunged 12.3% in premarket trading on Thursday after sales of the company’s Covid-19 vaccine fell short of Wall Street analysts’ estimates by more than a billion dollars. The company reported total revenue of $5 billion for the third quarter of the year, […]
Read More